Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Theta Burst Stimulation for Schizophrenia
Theta Burst Stimulation for Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Theta Burst Stimulation for Schizophrenia
Theta Burst Stimulation for Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
A Pilot Open-label Trial of Pentosan Polysulfate Sodium and Meclofenamic Acid As Adjunctive Treatments in Patients With Psychotic Disorders
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
1884
mi
from 98109
Houston, TX
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
A Pilot Open-label Trial of Pentosan Polysulfate Sodium and Meclofenamic Acid As Adjunctive Treatments in Patients With Psychotic Disorders
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
1884
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1770
mi
from 98109
Austin, TX
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1675
mi
from 98109
Richardson, TX
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1675
mi
from 98109
Richardson, TX
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1782
mi
from 98109
Little Rock, AR
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1633
mi
from 98109
Rogers, AR
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1633
mi
from 98109
Rogers, AR
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
976
mi
from 98109
Cerritos, CA
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
976
mi
from 98109
Cerritos, CA
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational site
964
mi
from 98109
Culver City, CA
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational site
964
mi
from 98109
Culver City, CA
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
982
mi
from 98109
Garden Grove, CA
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
982
mi
from 98109
Garden Grove, CA
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1065
mi
from 98109
Lemon Grove, CA
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1065
mi
from 98109
Lemon Grove, CA
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
2719
mi
from 98109
Hialeah, FL
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
2719
mi
from 98109
Hialeah, FL
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1733
mi
from 98109
Chicago, IL
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1721
mi
from 98109
Saint Louis, MO
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1721
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
2389
mi
from 98109
Berlin, NJ
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
2389
mi
from 98109
Berlin, NJ
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1704
mi
from 98109
Hoffman Estates, IL
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1704
mi
from 98109
Hoffman Estates, IL
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
874
mi
from 98109
Las Vegas, NV
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
874
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1734
mi
from 98109
Garland, TX
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1734
mi
from 98109
Garland, TX
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1985
mi
from 98109
Flowood, MS
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1985
mi
from 98109
Flowood, MS
Click here to add this to my saved trials
Examining Persistence in Smokers With Schizophrenia
Examining Persistence in Smokers With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Rutgers Robert Wood Johnson Medical School
2389
mi
from 98109
New Brunswick, NJ
Examining Persistence in Smokers With Schizophrenia
Examining Persistence in Smokers With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Rutgers Robert Wood Johnson Medical School
2389
mi
from 98109
New Brunswick, NJ
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
1782
mi
from 98109
Little Rock, AR
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Kashinath Yadalam
1953
mi
from 98109
Lake Charles, LA
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Kashinath Yadalam
1953
mi
from 98109
Lake Charles, LA
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Pillar Clinical Research, LLC
1676
mi
from 98109
Dallas, TX
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Pillar Clinical Research, LLC
1676
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Bugát Pál Kórház-Rendelőintézet, Rehabilitációs Elmegyógyászati Osztály
5465
mi
from 98109
Gyongyos,
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Bugát Pál Kórház-Rendelőintézet, Rehabilitációs Elmegyógyászati Osztály
5465
mi
from 98109
Gyongyos,
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CNRI - Los Angeles LLC
968
mi
from 98109
Pico Rivera, CA
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CNRI - Los Angeles LLC
968
mi
from 98109
Pico Rivera, CA
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Medical Research
2178
mi
from 98109
Atlanta, GA
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Medical Research
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
1782
mi
from 98109
Little Rock, AR
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CNRI - San Diego, LLC
1066
mi
from 98109
San Diego, CA
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CNRI - San Diego, LLC
1066
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research
1770
mi
from 98109
Austin, TX
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
A Phase 1 Randomized, 2-way, Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Cctmg/Parexel
955
mi
from 98109
Glendale, CA
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
A Phase 1 Randomized, 2-way, Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Cctmg/Parexel
955
mi
from 98109
Glendale, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
A Phase 1 Randomized, 2-way, Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research
1770
mi
from 98109
Austin, TX
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
A Phase 1 Randomized, 2-way, Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia: A Prospective 3-month Pilot Study
Status: Enrolling
Updated:  12/31/1969
Clinical and Translational Science Center, Weill Cornell Medicine, 525 E 68th Street, F-260
2402
mi
from 98109
New York, NY
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia: A Prospective 3-month Pilot Study
Status: Enrolling
Updated: 12/31/1969
Clinical and Translational Science Center, Weill Cornell Medicine, 525 E 68th Street, F-260
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated:  12/31/1969
West LA VAHCS
959
mi
from 98109
Los Angeles, CA
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated: 12/31/1969
West LA VAHCS
959
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated:  12/31/1969
University of Missouri
1495
mi
from 98109
Kansas City, MO
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated: 12/31/1969
University of Missouri
1495
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated:  12/31/1969
Mental Health Center of Greater Manchester
2447
mi
from 98109
Manchester, NH
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated: 12/31/1969
Mental Health Center of Greater Manchester
2447
mi
from 98109
Manchester, NH
Click here to add this to my saved trials
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated:  12/31/1969
University of South Carolina
2322
mi
from 98109
Columbia, SC
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated: 12/31/1969
University of South Carolina
2322
mi
from 98109
Columbia, SC
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.
A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, 6-Week, In-Patient Study to Assess Efficacy and Safety of HP-3070 in Subjects Diagnosed With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Noven Pharmaceuticals, Inc.
2262
mi
from 98109
New York, NY
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.
A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, 6-Week, In-Patient Study to Assess Efficacy and Safety of HP-3070 in Subjects Diagnosed With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Noven Pharmaceuticals, Inc.
2262
mi
from 98109
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CIMU Bellflower
977
mi
from 98109
Cerritos, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CIMU Bellflower
977
mi
from 98109
Cerritos, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Woodland Research Northwest
1634
mi
from 98109
Rogers, AR
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Woodland Research Northwest
1634
mi
from 98109
Rogers, AR
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network
982
mi
from 98109
Garden Grove, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network
982
mi
from 98109
Garden Grove, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Synergy Research San Diego
1065
mi
from 98109
Lemon Grove, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Synergy Research San Diego
1065
mi
from 98109
Lemon Grove, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Apostle Clinical Trials, Inc
982
mi
from 98109
Long Beach, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Apostle Clinical Trials, Inc
982
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
NRC Research Institute
984
mi
from 98109
Orange, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
NRC Research Institute
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CNRI - Los Angeles LLC
968
mi
from 98109
Pico Rivera, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CNRI - Los Angeles LLC
968
mi
from 98109
Pico Rivera, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CNRI - San Diego, LLC
1066
mi
from 98109
San Diego, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CNRI - San Diego, LLC
1066
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Galiz Research
2719
mi
from 98109
Hialeah, FL
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Galiz Research
2719
mi
from 98109
Hialeah, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Research, Inc.
2722
mi
from 98109
Hollywood, FL
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Research, Inc.
2722
mi
from 98109
Hollywood, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Medical Research
2178
mi
from 98109
Atlanta, GA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Medical Research
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CBH Health, LLC
2306
mi
from 98109
Gaithersburg, MD
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CBH Health, LLC
2306
mi
from 98109
Gaithersburg, MD
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Precise Research Centers MS
mi
from 98109
Flowood, MS
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Precise Research Centers MS
mi
from 98109
Flowood, MS
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
874
mi
from 98109
Las Vegas, NV
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
874
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials